Forsiden ENOVA

Group photo from 2nd enova workshop

ENOVA is a science and technology “Network on Vaccine Adjuvants”, funded by COST through the EU Framework Programme Horizon 2020. ENOVA is coordinated by the Vaccine Formulation Institute (UK) and brings together European experts and stakeholders working in different areas of adjuvant and vaccine R&D, including both prophylactic and therapeutic applications as well as human and veterinary vaccines.  ENOVA’s members include industry, academic, and government institutions. The ultimate goals of the network are to facilitate communication and the exchange of information among its membership, to ensure that new discoveries are widely disseminated so that their potential can be of optimal benefit, to promote the best use of existing adjuvant technologies, and to encourage and support the development of novel adjuvants.

Log in (restricted)


  • Courses and webinars from CORBEL Nov. 19, 2019 1:26 AM

    The EU funded project CORBEL (Coordinated Research Infrastructures Building Enduring Life-science Services) have open spots for webinars and courses:

  • Job opportunities in Lille, France Nov. 19, 2019 1:01 AM

    3 positions opened for 2020 in laboratory to work on alternative (host-directed) therapies of bacterial infections. PhD or engineer with strong backgoround in cell biology, immunity or bioinformatics wanted.

    For more information, click here

  • Job opportunity in Lyon, France Oct. 21, 2019 9:34 PM
  • New Call for training modules. Deadline 1 July 2019 June 13, 2019 10:18 AM

    TRANSVAC: European Training in Vaccinology

    M10 - Assay Development and Validation-Application of SPR Technologies in Vaccine development and manufacturing.

    Venue: Fraunhofer IME, Aachen Germany

    Date: 10-11 October 201 9

    M11 - Process Development and scale-up of recombinant protein vaccines.

    Venue: Fraunhofer IME, Aachen Germany

    Date: 7-8 October 201 9

    M12 - Requirements for GMP production

    Venue: Fraunhofer IME, Aachen Germany

    Date: 14-15 October 201 9


06 Feb.
Oxford, England

3rd Human Challenge Trials in Vaccine Development

07 Feb.
Oxford, England

3rd Human Challenge Trials in Vaccine Development

16 Mar.